Filter
8456
Filtered Results: 8456
Text search:
medicines
use
Featured
Recommendations
771
New Publications
2065
Language
Document type
No document type
4543
Studies & Reports
1501
Guidelines
1160
Manuals
443
Strategic & Response Plan
259
Fact sheets
200
Training Material
160
Situation Updates
75
Resource Platforms
34
Brochures
28
Infographics
24
Online Courses
16
Videos
11
App
2
Countries / Regions
India
385
Global
315
Kenya
229
South Africa
197
Ethiopia
165
Uganda
152
Sierra Leone
151
Nepal
147
Western and Central Europe
145
Africa
144
Nigeria
143
Latin America and the Carribbean
138
Liberia
136
Malawi
118
Bangladesh
114
Tanzania
113
Myanmar / Burma
103
Zambia
102
Ukraine
98
Ghana
95
Syria
92
Rwanda
86
Brazil
80
Congo, Democratic Republic of
76
Philippines
66
Eastern Europe
63
Mozambique
60
Russia
60
Namibia
58
Zimbabwe
56
South–East Asia Region
54
Guinea
45
Senegal
45
Venezuela
44
Burkina Faso
43
Asia
43
Germany
41
East and Southern Africa
41
West and Central Africa
41
Lesotho
40
Cambodia
38
Indonesia
38
Middle East and North Africa
38
South Sudan
36
Cameroon
35
Haiti
35
Yemen
32
Paraguay
30
Colombia
29
Botswana
27
Eastern Europe and Central Asia
26
Peru
24
Eswatini/ Swaziland
22
Benin
21
Mali
20
USA
19
Sudan
19
Ecuador
18
Bolivia
18
Pakistan
17
Afghanistan
17
Lebanon
17
Madagascar
17
Chile
17
Thailand
16
Angola
16
Vietnam
16
Côte d’Ivoire / Ivory Coast
14
Jordan
13
China
13
Western Pacific Region
13
Moldova
13
Argentina
12
Sri Lanka
12
Niger
11
Somalia
11
Central African Republic
11
Tajikistan
11
Spain
11
Iraq
10
Georgia
10
North America
10
Chad
9
Mexico
9
Albania
9
Southern Africa
9
North Macedonia
8
Laos
8
United Kingdom
8
El Salvador
7
Libya
7
Palestine
7
Kyrgyzstan
7
Portugal
7
Guinea-Bissau
6
Turkey
6
Egypt
6
Iran
6
Kazakhstan
6
Saudi Arabia
5
Papua New Guinea
5
Guatemala
5
Poland
5
Jamaica
5
Belarus
5
Morocco
4
Hungary
4
Burundi
4
Nicaragua
4
Bhutan
4
Canada
4
Estonia
4
Romania
4
Gambia
3
Malaysia
3
Serbia
3
Honduras
3
Greece
3
Fiji
3
Armenia
3
Timor Leste/ East Timor
3
Qatar
3
Uruguay
3
Japan
3
France
3
Mauritius
3
Tunisia
3
Togo
2
Mauritania
2
Other region
2
Italy
2
Mongolia
2
Congo-Brazzaville
2
Bulgaria
2
Lithuania
2
Uzbekistan
2
Australia
2
Gabon
2
Turkmenistan
2
South Korea
2
Israel
2
Bosnia and Herzegovina
2
Singapore
1
Dominican Republic
1
Switzerland
1
Cuba
1
Solomon Islands
1
Djibouti
1
Slovakia
1
Denmark
1
Belgium
1
Maldives
1
Norway
1
French Guyana
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
3089
Clinical Guidelines
702
Public Health
486
Women & Child Health
384
Key Resources
261
Capacity Building
173
Pharmacy & Technologies
104
Annual Report MEDBOX
3
Toolboxes
COVID-19
794
Mental Health
746
HIV
666
TB
496
AMR
361
Caregiver
259
Disability
253
Pharmacy
244
Planetary Health
239
NCDs
232
Ebola
224
NTDs
213
Conflict
200
Rapid Response
195
Refugee
159
Global Health Education
121
Natural Hazards
81
Health Financing Toolbox
63
Zika
55
Specific Hazards
46
Social Ethics
40
Cholera
30
Polio
22
Health Financing
2
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga...
Female Genital Schistosomiasis (FGS) is a gynaecological disease caused by Schistosoma haematobium, a parasitic worm that is acquired by skin contact with freshwater contaminated by schistosome cerceriae. Communities in which the infection is most endemic have limited access to clean water and healt...
Cholera is a diarrheal disease caused by the bacterium Vibrio cholera. The infection primarily spreads through contaminated water and food. Symptoms include the onset of acute diarrhea and/or vomiting, muscle cramps, and body weakness. If untreated, the infection can result in rapid dehydration and ...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
Mycetoma is a chronic infectious disease of the subcutaneous tissue with a high morbidity. This disease has been reported from countries between 30°N and 15°S since 1840 but the exact burden of disease is not known. It is currently unknown what the incidence, prevalence and the number of reported ...
Scabies is a global health concern disproportionately affecting vulnerable populations such as refugees and asylum seekers. Greece is a main point of entry in Europe for refugees, but epidemiological data on scabies in this population are scarce. We aimed to describe the epidemiology of scabies, inc...
Snakebite envenoming constitutes a serious medical condition that primarily affects residents of rural communities in Africa, Asia, Latin America, and New Guinea. It is an occupational, environmental, and domestic health hazard that exacerbates the already impoverished state of these communities. Co...
The epidemiology of the disease is mediated by the interaction of the parasite (trypanosome) with the vectors (tsetse flies), as well as with the human and animal hosts within a particular environment. Related to these interactions, the disease is confined in spatially limited areas called “foci...
There has been no systematic comparison of how the policy response to past infectious disease outbreaks and epidemics was funded. This study aims to collate and analyse funding for the Ebola epidemic and Zika outbreak between 2014 and 2019 in order to understand the shortcomings in funding reporting...
The majority of Countdown countries did not reach the fourth Millennium Development Goal (MDG 4) on reducing child mortality, despite the fact that donor funding to the health sector has drastically increased. When tracking aid invested in child survival, previous studies have exclusively focused on...
To provide information on trends on official development assistance (ODA) disbursement patterns for
reproductive health activities in 18 conflict-affected countries
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are ...
Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan Africa (SSA) accounting for about 35% of all deaths, after a composite of communicable, maternal, neonatal, and nutritional diseases. Despite prior perception of low NCDs mortality rates, current evidence suggests t...
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients wit...
Air pollution is a major environmental risk factor and contributor to chronic, noncommunicable diseases (NCDs). However, most public health approaches to NCD prevention focus on behavioural and biomedical risk factors, rather than environmental risk factors such as air pollution. This article discus...
The article discusses the significant impact of chronic obstructive pulmonary disease (COPD) as a global health issue, with cigarette smoking as the main risk factor. However, in developing countries, the causes of COPD are often multifactorial, involving environmental tobacco smoke, biomass fuel sm...
Silicosis is not a new disease; the impact of silica dust on respiratory function was observed by Hippocrates in 430 B.C. and in the 16th century by Agricol. In 1713, Rammazini described silicotic nodules in post-mortems of stone cutters presenting with respiratory symptoms. In the mid-late 1800s,...
This article summarises the process involved in developing the updated guideline and includes an infographic to highlight key IPC recommendations from the guideline, following the patient care pathway from the community to a healthcare facility to discharge.
In a prospective cohort study in Bangwe primary care clinic, Blantyre, Malawi, all adults (18 years or older) presenting with an acute illness were screened for TB symptoms (cough, fever, night sweats, weight loss). Demographic characteristics were linked to exit interview by fingerprint bioidentifi...
